Amgen files update to Tavneos label as FDA escalates push to withdraw
Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA.
The company filed a supplement on Wednesday that would add more information to the warning ...
Read the full article on the original site.
Read Full Article